No differences in the marker of proliferation, Ki-67 labeling index, tumor suppressor p53 expression, or prognostic grades [using the Trouillas classification (68)] were observed between silent somatotroph adenomas and secreting somatotroph adenomas. This evidence concerns the gene TP53 and growth hormone secreting pituitary adenoma 1.